Advertisement

Topics

Herceptin biosimilars are first challenge to Roche’s grip on HER2-targeted agents, says report

07:59 EDT 2 Aug 2017 | thePharmaLetter

The human epidermal growth factor receptor type 2 (HER2)-positive breast cancer space across the eight…

Original Article: Herceptin biosimilars are first challenge to Roche’s grip on HER2-targeted agents, says report

NEXT ARTICLE

More From BioPortfolio on "Herceptin biosimilars are first challenge to Roche’s grip on HER2-targeted agents, says report"

Quick Search
Advertisement
 

Relevant Topic

Women's Health
Women's Health - key topics include breast cancer, pregnancy, menopause, stroke Follow and track Women's Health News on BioPortfolio: Women's Health News RSS Women'...